Landon A. Burcham
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Graduate Student Researcher
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Landon A. Burcham's research focuses on the application of CRISPR-Cas9 genome editing technologies, particularly in the context of Duchenne muscular dystrophy. Their work investigates the delivery challenges associated with these advanced editing tools and explores the complex genomic and transcriptomic changes that occur following AAV-CRISPR therapy. This research utilizes long-read sequencing to provide a detailed understanding of the molecular alterations resulting from gene editing interventions. Burcham collaborates with researchers including Christopher E. Nelson, Made Harumi Padmaswari, Shilpi Agrawal, and Allie Ivy at the University of Arkansas at Fayetteville, with whom they have co-authored multiple publications. Their scholarly output includes two publications, with a total of 15 citations, and an h-index of 1, indicating early-stage research contributions.
Metrics
- h-index: 1
- Publications: 2
- Citations: 15
Selected Publications
-
Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy (2025)
-
Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy (2023)
Collaboration Network
Top Collaborators
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
Similar Researchers
Based on overlapping research topics